Alimera Sciences (ALIM)
(Delayed Data from NSDQ)
$5.60 USD
+0.04 (0.72%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $5.60 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for Alimera Sciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.13 | -18.11 | -4.37 | -5.34 | -10.44 |
Depreciation/Amortization & Depletion | 9.77 | 3.86 | 3.54 | 3.65 | 3.48 |
Net Change from Assets/Liabilities | -15.80 | 2.69 | -1.35 | -1.39 | -0.18 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 11.90 | 1.58 | -1.05 | 0.89 | 2.99 |
Net Cash From Operating Activities | -14.26 | -9.98 | -3.22 | -2.19 | -4.15 |
Property & Equipment | -0.26 | -0.26 | -0.62 | -0.62 | -0.17 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -75.27 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -75.53 | -0.26 | -0.62 | -0.62 | -0.17 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 79.77 | 0.10 | 10.04 | 0.05 | 0.90 |
Issuance (Repayment) of Debt | 22.02 | -0.29 | -0.22 | 3.85 | 2.19 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -5.29 | -0.11 | 0.00 | -0.02 | -2.23 |
Net Cash from Financing Activities | 96.50 | -0.30 | 9.82 | 3.88 | 0.87 |
Effect of Exchange Rate Changes | 0.08 | -0.71 | -0.68 | 0.71 | -0.16 |
Net Change In Cash & Equivalents | 6.79 | -11.24 | 5.30 | 1.78 | -3.62 |
Cash at Beginning of Period | 5.30 | 16.54 | 11.24 | 9.46 | 13.08 |
Cash at End of Period | 12.09 | 5.30 | 16.54 | 11.24 | 9.46 |
Diluted Net EPS | -0.84 | -2.59 | -0.66 | -1.04 | -2.19 |
Fiscal Year End for Alimera Sciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -6.25 | -20.13 | -16.35 | -15.00 |
Depreciation/Amortization & Depletion | NA | 3.33 | 9.77 | 6.46 | 3.04 |
Net Change from Assets/Liabilities | NA | 1.09 | -15.80 | -16.96 | -3.79 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.26 | 11.90 | 8.82 | 7.54 |
Net Cash From Operating Activities | NA | -0.57 | -14.26 | -18.03 | -8.21 |
Property & Equipment | NA | -0.02 | -0.26 | -0.18 | -0.17 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | -75.27 | -75.27 | -75.27 |
Net Cash from Investing Activities | NA | -0.02 | -75.53 | -75.45 | -75.44 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.04 | 79.77 | 79.77 | 78.98 |
Issuance (Repayment) of Debt | NA | 4.87 | 22.02 | 22.11 | 22.25 |
Increase (Decrease) Short-Term Debt | NA | -1.88 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.06 | -5.29 | -5.31 | -4.11 |
Net Cash from Financing Activities | NA | 2.97 | 96.50 | 96.58 | 97.12 |
Effect of Exchange Rate Changes | NA | -0.12 | 0.08 | -0.09 | 0.03 |
Net Change In Cash & Equivalents | NA | 2.26 | 6.79 | 3.01 | 13.50 |
Cash at Beginning of Period | NA | 12.09 | 5.30 | 5.30 | 5.30 |
Cash at End of Period | NA | 14.35 | 12.09 | 8.32 | 18.81 |
Diluted Net EPS | NA | -0.12 | 1.25 | -0.06 | -1.32 |